Overview
Giuliana Ferrante practices in Verona, Italy. Ms. Ferrante is rated as an Advanced expert by MediFind in the treatment of Asthma in Children. Her top areas of expertise are Asthma, Asthma in Children, Allergic Rhinitis, and Bronchitis.
Her clinical research consists of co-authoring 107 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 5 articles in the study of Asthma in Children.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AsthmaMs. Ferrante isDistinguished. Learn about Asthma.
- Advanced
- Allergic RhinitisMs. Ferrante isAdvanced. Learn about Allergic Rhinitis.
- Asthma in ChildrenMs. Ferrante isAdvanced. Learn about Asthma in Children.
- BronchitisMs. Ferrante isAdvanced. Learn about Bronchitis.
- StridorMs. Ferrante isAdvanced. Learn about Stridor.
- Experienced
- Atopic DermatitisMs. Ferrante isExperienced. Learn about Atopic Dermatitis.
- Bronchopulmonary DysplasiaMs. Ferrante isExperienced. Learn about Bronchopulmonary Dysplasia.
- Childhood PancreatitisMs. Ferrante isExperienced. Learn about Childhood Pancreatitis.
- Congenital Diaphragmatic HerniaMs. Ferrante isExperienced. Learn about Congenital Diaphragmatic Hernia.
- Conjunctivitis (Pink Eye)Ms. Ferrante isExperienced. Learn about Conjunctivitis (Pink Eye).
- COVID-19Ms. Ferrante isExperienced. Learn about COVID-19.